ISSN 2398-2942      

Meticillin-resistant Staphylococcus aureus


Synonym(s): MRSA; meticillin-resistant S.aureus, MR-S. aureus




  • Genus: Staphylococcus.
  • Family: Micrococcaceae.
  • Species: aureus.
  • Antimicrobial-resistance: carries additional genetic marker mecA for methicillin-resistance and broad β-lactam resistance.


  • Gk: staphyle - bunch of grapes; coccus - grain or berry; Latin: aureus - golden.
  • Meticillin (INN; international non-proprietory name) or Methicillin (USAN; United States adopted names): semisynthetic penicillin introduced for clinical use in 1959 but no longer manufactured today. Marker for broad β-lactam antibiotic resistance.

Active Forms

This article is available in full to registered subscribers

Sign up now to start a free trial to access all Vetlexicon articles, images, sounds and videos, or Login

Clinical Effects


  • See under 'Distribution'.


  • Skin and mucosae of healthy animals.
  • Adhere to skin squames and hair.
  • Environmental contamination through squames and hair shed by the host.
  • May inhabit the gastrointestinal tract.
  • Preferred niche: nostrils.
  • Humans (nostrils and throat) are the preferred host for MRSA isolates most commonly.


  • Reproduction by binary fission.


  • Direct and indirect transmission.
  • In human hospitals, most important route via hand contact.
  • Endogenous infection (opportunistic infection by commensal strains).
  • Transmission between pets and in-contact people in both directions but human-to-pet considered original direction as isolates typically human-healthcare associated strains ("reverse zoonosis").

Pathological effects

  • MRSA infections show the same pathology as those due to meticillin-susceptible S. aureus and other Staphlococcus spp.
  • Typicaly skin and ear infections, traumatic and post-surgical wound infections, often associated with implants, suture material and biofilm.
  • Other organs can be involved in infection (eg urinary tract, respiratory tract) as for other staphylococci.
  • No known lasting immunity after recovery.
  • Severe, life-threatening soft tissue infections reported in people with toxin-producing PVL-positive MRSA (currently rare in pets).

Other Host Effects

  • Same as for other Staphylococcus spp and as for meticillin-susceptible S. aureus.
  • MRSA can colonize skin and mucous membranes of healthy animals and predispose to subsequent (endogenous) MRSA infection.
  • Has host-preference but is not host-specific, ie can contaminate or colonize non-preferred host species and cause infection in immune-compromised individuals (opportunistic).


Control via chemotherapies

  • All MRSA strains are resistant to all penicillins, most cephalosporins and carbapenems.
  • Topical antibacterial therapy should be used whenever appropriate (surface and superficial skin, wound and ear infections).
  • 2-4% chlorhexidine Chlorhexidine preparations and/or fusidic acid Fusidic acid containing creams have good efficacy if owner and pet are compliant.
  • Individual isolates can be susceptible to tetracyclines, lincomycin, potentiated sulfonamide.
  • Antibacterial choice must always be based on sensitivity testing.
  • Prognosis can be good depending on prognosis of underlying primary problem that led to infection.


  • None commercially available.

Other countermeasures

  • For known MRSA patients: barrier nursing:
    • Outpatients should be booked in for last appointment of the day.
    • Waiting and walking in the practice should be minimized.
    • Rigorous hand hygiene (frequent and thorough).
    • Cleaning and disinfection of practice environment after every patient.


This article is available in full to registered subscribers

Sign up now to start a free trial to access all Vetlexicon articles, images, sounds and videos, or Login

Further Reading


Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Morris D O, Loeffler A, Davis M F et al (2017) Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 28 (3), 304-e69 PubMed.
  • Harrison E M, Weinert L A, Holden M T et al (2014) A shared population of epidemic methicillin-resistant Staphylococcus aureus 15 circulates in humans and companion animals. mBio (3), e00985-13 PubMed.
  • Singh A, Walker M, Rousseau J et al (2013) Methicillin-resistant staphylococcal contamination of clothing worn by personnel in a veterinary teaching hospital. Vet Surg 42 (6), 643-648 PubMed.
  • McCarthy A J, Lindsay J A, Loeffler A (2012) Are all meticillin-resistant Staphylococcus aureus (MRSA) equal in all hosts? Epidemiological and genetic comparison between animal and human MRSA. Vet Dermatol 23 (4), 267-275, e53-54 PubMed.
  • Walther B, Hermes J, Cuny C et al (2012) Sharing more than friendship--nasal colonization with coagulase-positive staphylococci (CPS) and co-habitation aspects of dogs and their owners. PLoS One (4), e35197 PubMed.
  • García-Álvarez L, Holden M T, Lindsay H et al (2011) Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 11 (8), 595-603 PubMed.
  • Loeffler A, Pfeiffer D U, Lloyd D H et al (2010) Meticillin-resistant Staphylococcus aureus carriage in UK veterinary staff and owners of infected pets: new risk groups. J Hosp Infect 74 (3), 282-288 PubMed.
  • Loeffler A, Lloyd D H (2010) Companion animals: a reservoir for methicillin-resistant Staphylococcus aureus in the community? Epidemiol Infect 138 (5), 595-605 PubMed.
  • Loeffler A, Pfeiffer D U, Lindsay J A et al (2010) Lack of transmission of methicillin-resistant Staphylococcus aureus (MRSA) between apparently healthy dogs in a rescue kennel. Vet Microbiol 141 (1-2), 178-181 PubMed.
  • Soares Magalhães R J, Loeffler A, Lindsay J et al (2010) Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in dogs and cats: a case-control study. Vet Res 41 (5), 55 PubMed.
  • Weese J S, Dick H, Willey B M et al (2006) Suspected transmission of methicillin-resistant Stapylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 115 (1-3), 148-155 PubMed.
  • Rankin S, Roberts S, O'Shea K et al (2005) Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet Microbiol 108 (1-2), 145-148 PubMed.
  • van Duijkeren E, Wolfhagen M J, Heck M E et al (2005) Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol 43 (12), 6209-6211 PubMed.
  • Duquette R A & Nuttall T J (2004) Methicillin-resistant Staphylococcus aureus in dogs and cats: an emerging problem? JSAP 45 (12), 591-597 PubMed.
  • Owen M R, Moores A P & Coe R J (2004) Management of MRSA septic arthritis in a dog using a gentamicin-impregnated collagen sponge. JSAP 45 (12), 609-612 PubMed.
  • van Duijkeren E, Wolfhagen M J, Box A T et al (2004) Human-to-dog transmission of Methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 10 (12), 2235-2237 PubMed.
  • Manian F A (2003) Asymptomatic nasal carrriage of mupirocin, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 36 (2), e26-28 PubMed.
  • Seguin J C, Walker R D, Caron J P et al (1999) Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: Potential human-to-animal-transmission. J Clin Microbiol 37 (5), 1459-1463 PubMed.
  • Tomlin J, Pead M J, Lloyd D H et al (1999) Methicillin-resistant Staphylococcus aureus infections in 11 dogs. Vet Rec 144 (3), 60-64 PubMed.
  • Cefai C, Ashurst S & Owens C (1994) Human carriage of methicillin-resistant Staphylococcus aureus linked with pet dog. Lancet 344 (8921), 539-540 PubMed.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!


To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code